[HTML][HTML] Neuroinflammation: friend and foe for ischemic stroke

RL Jayaraj, S Azimullah, R Beiram, FY Jalal… - Journal of …, 2019 - Springer
Ischemic stroke is characterized by arterial occlusion due to embolus or … ischemic stroke
largely depend on the artery that is occluded, which in turn determines the size of the ischemic

Deregulated protein kinases: friend and foe in ischemic stroke

S Appunni, D Gupta, M Rubens, V Ramamoorthy… - Molecular …, 2021 - Springer
Ischemic stroke is the third leading cause of mortality … family occur during the period of
ischemia/reperfusion. However, … in the evolution of stroke pathophysiology. Activation of ROCK-, …

The role of endogenous tissue-type plasminogen activator in neuronal survival after ischemic stroke: friend or foe?

J Zhu, Y Wan, H Xu, Y Wu, B Hu, H Jin - Cellular and Molecular Life …, 2019 - Springer
… and how endogenous tPA mediates ischemic neuronal death and survival. Finally, we
analyze how endogenous tPA affects neuron fate in ischemic stroke in a comprehensive view. …

Erythropoietin in stroke therapy: friend or foe

R Souvenir, D Doycheva, JH Zhang… - Current medicinal …, 2015 - ingentaconnect.com
… Alternately, a hemorrhagic stroke could lead to an ischemic stroke (ASA; WHO). Thus, we
will focus primarily on cerebral ischemia. The two main types of stroke can be further broken …

Immediate early gene expression in response to cerebral ischemia: friend or foe?

PT Akins, PK Liu, CY Hsu - Stroke, 1996 - Am Heart Assoc
… the treatment of acute ischemic stroke. Neurorehabilitation after cerebral ischemia is a gradual
process … may suggest novel strategies to improve clinical outcome after ischemic strokes. …

[HTML][HTML] Friend or foe?–B cells in stroke

D Berchtold, L Weitbrecht, C Meisel, A Meisel - Neuroforum, 2019 - degruyter.com
… of ischemic stroke. In this review, we will focus on the role of B cells in the ischemic brain …
and antibody-independent mechanisms in the development of post-stroke cognitive deficits. …

[HTML][HTML] Post-stroke neurogenesis: friend or foe?

MI Cuartero, A García-Culebras… - Frontiers in Cell and …, 2021 - frontiersin.org
… the adult SVZ, inducing functional improvement after stroke. Furthermore, the blockade of
IL-1 receptor after experimental ischemic stroke resulted in functional improvement of the mice …

[HTML][HTML] Patent foramen ovale: friend or foe?

R Castello, TG Brott - Journal of the American College of Cardiology, 2003 - jacc.org
… of stroke, primarily in younger patients. In a recent multicenter prospective European study
that included 581 patients with ischemic stroke, the recurrent stroke … with ischemic stroke. The …

[HTML][HTML] Neuroinflammation in post-ischemic neurodegeneration of the brain: friend, foe, or both?

R Pluta, S Januszewski, SJ Czuczwar - International Journal of Molecular …, 2021 - mdpi.com
… In this review, we focus on the issues related to the neuroinflammation that occurs in the
brain tissue after ischemia, with particular emphasis on ischemic stroke and its potential …

Antihypertensive therapy: friend or foe in stroke?

C Bankhead - Inpharma Weekly, 1998 - Springer
… In the clinical setting of acute ischemic stroke, current clinical guidelines, including those
developed by the American Heart Association (AHA), do not support the use of …